GL1X · GenesisL1 explorer

Research workbench

Co-crystal structure of human SMYD3 with isoxazole amides inhibitors

Analyse Co-crystal structure of human SMYD3 with isoxazole amides inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6P6K
Type
protein
Length
424 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone-lysine N-methyltransferase SMYD3
EC
2.1.1.43
UniProt
Q9H7B4
Ligands
SAM, L0J, ZN, MG
Pockets
4 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 51% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43)protein42451% helix, 13% strandQ9H7B4

Ligands and binding sites

  • SAM · S-adenosylmethionine · ligand · chains A
  • L0J · N-{1-[(2-aminoethyl)sulfonyl]piperidin-4-yl}-5-cyclopropyl-1,2-oxazole-3-carboxamide · ligand · chains A
  • ZN · Zinc ion · metal · 3 copies · chains A
  • MG · Magnesium ion · metal · 2 copies · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110240.800.8298EDO, SAM, L0J
21380.500.7920empty
31170.460.7826empty
4530.320.7713empty

Compared structures

  • 6P6K · Co-crystal Structure of human SMYD3 with Isoxazole Amides Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9H7B4 · AlphaFold monomer V2.0 prediction for histone-lysine N-methyltransferase SMYD3 (Q9H7B4) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.